THR-β agonist 4
THR-β agonist 4 is a potent agonist of THR-β. THR-β agonist 4 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021143706A1, compound 72) [1].
Product Specifications
CAS Number
2673409-25-9
UNSPSC
12352005
Target
Thyroid Hormone Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/thr-β-agonist-4.html
Solubility
10 mM in DMSO
Smiles
O=C1NC(N(C2=CC(Cl)=C(C(Cl)=C2)OC3=NC=C(C(S(=O)(NC)=O)=C3)O)N=C1C(F)F)=O
Molecular Formula
C16H11Cl2F2N5O6S
Molecular Weight
510.26
References & Citations
[1]Jingye Zhou, et al. Substituted triazinones as thyroid hormone receptor agonists. Patent WO2021143706A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Desfuroyl Ceftiofur Cysteine Disulfide (Contain 5% Ceftiofur) (>90%)
XTP3TPA (DCTPP1) (N-term) Rabbit Polyclonal Antibody
Contactin 3 (CNTN3) Human Gene Knockout Kit (CRISPR)
